Skip to main content
Molecular Therapy logoLink to Molecular Therapy
. 2021 Nov 12;29(12):3525–3527. doi: 10.1016/j.ymthe.2021.11.002

circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer

Yuting Sang, Bing Chen, Xiaojin Song, Yaming Li, Yiran Liang, Dianwen Han, Ning Zhang, Hanwen Zhang, Ying Liu, Tong Chen, Chen Li, Lijuan Wang, Wenjing Zhao, Qifeng Yang
PMCID: PMC8636162  PMID: 34774125

Main text

(Molecular Therapy 27, 1638–1652; September 2019)

In the originally published article, in Figures S2E, S3D, and S6D, the transwell images were incorrectly used. The assembly of Figure S6E was wrong. The corrected images are shown below. The errors do not impact the findings or conclusions of the study. The authors apologize for this error.

graphic file with name figs2.jpg

Figure S2. Features of MCF7/P and MCF7/TR cell lines

graphic file with name figs3.jpg

Figure S3. Hsa_circ_0025202 suppresses growth, metastasis and increases TAM sensitivity of HR-positive BC cells in vitro

graphic file with name figs6.jpg

Figure S6. Has_circ_0025202 sponges miR-182-5p to regulate the tumor progression and TAM sensitivity of BC cells


Articles from Molecular Therapy are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES